Search for: "GLAXOSMITHKLINE INC." Results 61 - 80 of 355
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Oct 2009, 12:13 pm
As a follow-up to last week's post about GlaxoSmithKline's new CME standards, it appears that some pharmaceuticals companies are not so keen on self-regulation. [read post]
30 Jun 2014, 4:23 am by Lawrence B. Ebert
Dow Chemical Company DuPont Eastman Chemical Company Electronics for Imaging Eli Lilly and Company Exxon Mobil Corporation General Electric General Mills Genzyme GlaxoSmithKline Henkel Corporation Hoffman-La Roche Illinois Tool Works Inc. [read post]
12 Jul 2010, 9:15 am by Margaret Grisdela
(c) Legal Expert Connections, Inc., 866-417-7025 www.legalexpertconnections.com [read post]
14 Jul 2010, 4:12 pm by Margaret Grisdela
(c) Legal Expert Connections, Inc., 866-417-7025 www.legalexpertconnections.com [read post]
3 Mar 2009, 6:22 am
Inc.'s Proscar [finasteride] also reduces the size of the prostate, and has a similar indication. [read post]
17 Aug 2011, 6:26 am by Phil
We are pleased to have Chad Deaton, CEO of Baker Hughes, Inc., as Monday's luncheon speaker. [read post]
26 Apr 2007, 2:32 am
BusinessWeek notes another Congressional hearing on patent reform will occur on April 26, with testimony from Kevin Sharer, chief executive of biotech company Amgen Inc.; Anthony Peterman, patent counsel for computer manufacturer Dell Inc.; and Gary Griswold, president and chief counsel of intellectual property at 3M Co.Dell Inc. is a member of the Coalition for Patent Fairness, comprised mainly of IT companies strongly seeking patent reform (including Amazon.com, Apple,… [read post]
27 Jun 2008, 6:35 am
Barr Pharmaceuticals Inc. and Mylan Inc. invalidated a patent (4,886,812) of Boehringer Ingelheim on Mirapex in D. [read post]
11 May 2011, 4:20 pm by Juliana Olsson
They’ve already announced plans to do exactly this to Howard Solomon, the CEO of Forest Laboratories, Inc. [read post]
24 Nov 2009, 9:59 pm
By Donald Zuhn -- In anticipation of the upcoming oral argument in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]